FLT3-ITD mutation + FLT3 D835Y
|
AML
|
FLT3-ITD mutation + FLT3 D835Y
|
AML
|
PHI-101 Sensitive: D – Preclinical
|
PHI-101 Sensitive: D – Preclinical
|
FLT3-ITD mutation + FLT3 D835Y
|
AML
|
FLT3-ITD mutation + FLT3 D835Y
|
AML
|
quizartinib + RAIN-32 Sensitive: D – Preclinical
|
quizartinib + RAIN-32 Sensitive: D – Preclinical
|